Thrombus formation on an Amplatzer closure device after left atrial appendage closure.

Sasayama S. Determinants of collateral development in patients with acute myocardial infarction. Clin Cardiol 1999;22:595–599. 36. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, Kuethe F, Ferrari M, Figulla HR. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 2004;110:1940–1945. 37. Werner GS, Richartz BM, Heinke S, Ferrari M, Figulla HR. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 2003;24: 1134–1142. 38. Kyriakides ZS, Psychari S, Chrysomallis N, Georgiadis M, Sbarouni E, Kremastinos DT. Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty. Heart 2002;87:61–66. 39. de Vries J, Anthonio RL, van den Heuvel AF, Tan ES, Jessurun GA, de Smet BJ, DeJongste MJ, Zijlstra F. Incidence and angiographic predictors of collateral function in patients with stable coronary artery disease scheduled for percutaneous coronary intervention. Catheter Cardiovasc Interv 2007;70:197–202. 40. Seiler C. The human coronary collateral circulation. Eur J Clin Invest 2010; 40:465–476. 41. Lin TH, Wang CL, Su HM, Hsu PC, Juo SH, Voon WC, Shin SJ, Lai WT, Sheu SH. Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease. Clin Chim Acta 2010;411:1688–1693. 42. Gaspardone A, Crea F, Perino M, Iamele M, Tomai F, Versaci F, Borioni R, Chiariello L, Gioffre PA. Risk factors in patients with different clinical and angiographic manifestations of ischemic heart disease. Cardiologia 1995;40: 679–684. 43. Suga T, Iso T, Shimizu T, Tanaka T, Yamagishi S, Takeuchi M, Imaizumi T, Kurabayashi M. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb 2011;18:670–683. 44. Shantikumar S, Ajjan R, Porter KE, Scott DJ. Diabetes and the abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2010;39:200–207. 45. Miyama N, Dua MM, Yeung JJ, Schultz GM, Asagami T, Sho E, Sho M, Dalman RL. Hyperglycemia limits experimental aortic aneurysm progression. J Vasc Surg 2010; 52:975–983.